News

  1. PCI Pharma Services Expands Biologics Leadership With New Center Of Excellence Facility In The Midwest 3/15/2023

    PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules.

  2. Aenova Introduces New Sterile Strategy 3/10/2023

    Aenova Group, a leading international contract developer and manufacturer for the pharmaceutical and healthcare industries, presents its new sterile strategy. In the future, the focus in sterile production will be on expanding the sterile site in Latina (Italy). There, portfolio and capacities are being expanded, especially in the area of prefilled syringes (PFS) as well as intramammary syringes.

  3. Shuttle Pharmaceuticals Engages UI Pharmaceuticals For Formulation And Clinical Batch Manufacture Of Ropidoxuridine For Brain Tumor Clinical Trial 3/9/2023

    Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals for formulation development and clinical batch manufacture of drug capsules of Ropidoxuridine.

  4. Marchesini Group Acquires Milan-Based Company M.A.R. S.p.A. 3/8/2023

    A new company is joining Marchesini Group. The latest arrival is M.A.R. S.p.A., a company from Lainate (Milan) specialised in the construction of machinery for packaging liquids and powders in glass and plastic bottles, syringes, carpules and other containers for the pharmaceutical industry. This operation further extends the array of technologies available to Marchesini Group for the packaging of products in the Pharma world.

  5. Grifols Enters Into Global Collaboration And Licensing Agreement With Selagine To Develop Immunoglobulin Eye Drops To Treat Dry Eye Disease 3/6/2023

    Grifols one of the world’s leading producers of plasma-derived medicines, today announced a global collaboration and licensing agreement with Selagine Inc, a company focused on developing novel therapeutics for ocular diseases, to treat dry eye disease (DED) with immunoglobulin eye drops.

  6. eXmoor Pharma And Vaccine Developer Imophoron Sign Process Development Partnership 2/22/2023

    eXmoor pharma, the cell and gene therapy partner specializing in accelerating the manufacturing journey from research to patients and Imophoron, the developer of a novel, next generation thermostable vaccine platform, ADDomer, to combat present and future infectious diseases, today announce the signature of a strategic process development partnership that includes a future GMP manufacturing route.

  7. CDMO Dalton Pharma Services Announces Major Expansion With New Filling And Lyophilization Technology 2/16/2023

    Dalton Pharma Services today announced a major strategic expansion of its sterile filling and pharmaceutical manufacturing capacity. The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, and cartridges under isolator technology.

  8. LIfT BioSciences And Minaris Regenerative Medicine Enter Into A Development And Manufacturing Partnership For N-LIfT Allogeneic Neutrophil Based Cell Therapy 2/16/2023

    LIfT BioSciences, a pioneering pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil progenitor based cell therapy, and Minaris Regenerative Medicine GmbH, a leading global contract development and manufacturing service provider for the cell and gene therapy industry, have entered into a development and manufacturing partnership for N-LIfT, LIfT’s first-in-class neutrophil progenitor based Leukocyte Infusion Therapy for the treatment of various cancer indications, including Pancreatic Cancer, Lung Cancer and other solid tumours.

  9. Windgap Medical Appoints Aaron Mann As CEO, Michael Samar As CFO 2/13/2023

    Both bring significant industry tenure and experience to their roles, and with Windgap Co-Founder Brent Buchine, will lead the company's continued growth in the field of complex injectable drug delivery solutions.

  10. Elektrofi Announces Collaboration With Thermo Fisher Scientific To Strengthen Manufacturing Capabilities For Future Clinical Trials 2/7/2023

    Elektrofi, a biotechnology company focused on drug formulation and delivery innovations, today announced a strategic contract manufacturing agreement with Thermo Fisher Scientific to support clinical manufacture of Elektrofi’s breakthrough ultra-high concentration subcutaneous products.